Meta, led by Mark Zuckerberg, is investing in humanoid robots through its Reality Labs division, focusing initially on ...

Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.

She noted the survival benefit with the combination was achieved even though 38% of patients in the enzalutamide-alone arm ...

Meta plans to invest in humanoid robots, initially developing AI, sensors and software for third-party use, Bloomberg reported, citing anonymous sources.